ClinicalTrials.gg
RecruitingNCT06716502PREVENTUpdated May 6, 2026

A New Portable Device for Non-invasive Ventilatory Support

An interventional study of Portable CPAP efficacy and Portable CPAP usability assessment in Healthy and Respiratory Disease, sponsored by Università Vita-Salute San Raffaele. Recruiting at 3 sites in Italy. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-06.

Sponsored by Università Vita-Salute San Raffaele · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by May 2026, 6 months ago, but the record still lists the study as recruiting.
  • Started Sep 2025; still recruiting 1 year 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Non-randomized
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 18 studies in Respiration Disorders with a site in Italy — 3 open to participants now, 4 under way, none of them phase 3. Respiration Disorders · Italy.

Started
2025
the only one that year
No phase
4 of 18
2 open now
Registered
18th of 18
by date

Among the 18 studies in Respiration Disorders with a site in Italy, this one is the only one that started in 2025, is one of 4 with no phase, and was the 18th registered.

Respiration Disorders

359 studies on the registry are indexed under Respiration Disorders; 64 are open to participants now.

Browse Respiration Disorders studies →

Open to participants now

3 of the 18 studies in Respiration Disorders with a site in Italy are open now. Recruiting first, the newest first:

All 3 open studies →

A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →

Who these studies take

Of the 45 Respiration Disorders studies recruiting now, 27 (60%) set no upper age limit and 13 (29%) stop at 75 or younger; 15 take children under 18; 21 take healthy volunteers.

This study: 65 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 18 studies in Respiration Disorders with a site in Italy, or all of them as a file.
02

Study summary

Acute respiratory failure is a medical emergency rapidly leading to death, if not timely treated. Prompt Continuous Positive Airway Pressure (CPAP) improves patient outcomes. However, pre-hospital CPAP is currently limited to healthcare providers due to the absence of easy-to-use and immediate devices specifically designed for the non-medical population.

The efficacy and usability of a new portable CPAP device will be assessed. This device is specifically designed for potential use in out-of-hospital scenarios involving acute respiratory failure. The evaluation will focus not only on the performance of the device but also on its easiness of use.

Read the detailed description

The efficacy and usability of a new portable CPAP device will be assessed in different clinical settings. The study will take place in three hospitals in Italy, with the objective of collecting data to support the future implementation of the device as a first-aid support tool for patients with respiratory failure in real-world scenarios.

03

Conditions studied

  • Healthy
  • Respiratory Disease

Keywords

  • CPAP
  • NIV
  • Respiratory failure
04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Arm 1

Inclusion Criteria:

  1. Age ≥65 years
  2. Clinically stable: non-hospitalized and not in acute illness
  3. no professional medical knowledge: no experience as a health care provider
  4. Ability to express as requested by the ethical committee

Arm 1 Exclusion Criteria: none

Arm 2

Inclusion Criteria:

  1. Hospitalized adult patient
  2. SpO2 of 90-93% in room air

Arm 2

Exclusion Criteria:

  1. Facial burns/trauma/recent facial or upper airway surgery
  2. Vomiting
  3. Fixed upper airway obstruction
  4. Undrained pneumothorax
  5. Recent upper gastrointestinal surgery
  6. Inability to protect the airway
  7. Bowel obstruction
  8. Patient refusal
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Healthy elderly individuals

    The performance and easiness to use of the device will be evaluated in patients' self-experience conditions, with elderly participants self-applying the device.

    Device: Portable CPAP usability assessment

  • Experimental
    Patients with mild oxygenation impairment

    The efficacy of the device will be assessed in patients with mild oxygenation impairment.

    Device: Portable CPAP efficacy

Interventions

  • DevicePortable CPAP efficacy

    The device will be tested in providing a PEEP comprised between 4-7,5 cmH2O

  • DevicePortable CPAP usability assessment

    The device usability will be evaluated in individual's self-experience tests, i.e., in conditions where the volunteer will self-apply the device.

06

What researchers measure

Primary outcomes

  1. Device easiness-to-use

    Volunteers in self-experience tests will be asked to assign a score depending on the easiness-to-use of the device and comfort during the device operation. A semantic differential scale will be used between "hard to use" (corresponding to the score 1) and "easy to use" (corresponding to the score 5). The best result is represented by a higher score, with 5 being the highest and 1 the lowest.

    Time frame: Up to 2 hours

  2. Duration of proper pressure delivery

    Total time of target pressure (4 - 15 cmH2O) during 15-min test

    Time frame: Up to 2 hours

  3. Battery power consumption and duration

    We will set 15 minutes of continuous device operation as an efficacy threshold and will assess the battery status at the end of each experiment.

    Time frame: Up to 2 hours

  4. Change in SpO2 level

    Change in SpO2 before and during the device application

    Time frame: Up to 2 hours

07

Study locations

1 of 3 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2025 (actual). Primary completion is estimated for May 2026, 8 months after the start.

Of 91 non-industry interventional studies with no phase under Respiration Disorders, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 37. This study's planned 8 months is below that.

Counting every sponsor, half of 111 studies reached it within 18 months; a quarter within 7 and three quarters within 35.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 14, 2024
First posted
Dec 4, 2024
StartActual
Sep 17, 2025
Primary completionEst.
May 19, 2026
CompletionEst.
Jun 19, 2026
Last update
May 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06716502
Lead sponsor
Università Vita-Salute San Raffaele
Collaborators
Azienda Ospedaliera Universitaria Integrata Verona, Città di Lecce Hospital
Responsible party
Giovanni Landoni (Director of the Research Center for Intensive Care and Anesthesiology of San Raffaele Scientific Institute, IRCCS San Raffaele) — Principal investigator
First posted
Dec 4, 2024
Start date
Sep 17, 2025
Primary completion
May 19, 2026 (estimated)
Completion
Jun 19, 2026 (estimated)
Last update
May 6, 2026

Study contacts

Giovanni Landoni, MD
Contact
landoni.giovanni@hsr.it
+39 022643 ext. 6151
Rosalba Lembo
Contact
lembo.rosalba@hsr.it
+39 022643 ext. 6151
Giovanni Landoni, MD
study chair · IRCCS San Raffaele

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion